Joe Gibbs Racing to feature SHINGRIX® as part of four-race agreement with GSK

Joe Gibbs Racing

Joe Gibbs Racing (JGR) announces today an agreement with GSK to feature SHINGRIX® (Zoster Vaccine Recombinant, Adjuvanted), over four races beginning in March.

GSK’s SHINGRIX will be featured on Denny Hamlin’s No. 11 Toyota Camry TRD at Phoenix Raceway (March 12), Atlanta Motor Speedway (March 19), and Richmond Raceway (April 2). In addition, SHINGRIX will be featured on the No. 20 Toyota Camry TRD with driver Christopher Bell at Martinsville Speedway (April 16).

“We are excited to announce our agreement with GSK to feature SHINGRIX,” said Joe Gibbs, owner of Joe Gibbs Racing. GSK is one of the world’s leading research-based pharmaceutical and healthcare companies that prioritize innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease.

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. GSK’s aim is to positively impact the health of 2.5 billion people over the next 10 years. Find out more at


Spread the love